Cardio Vascular Medical Device Sends Update to Shareholders
26 Ottobre 2009 - 1:30PM
PR Newswire (US)
Company Develops Innovative Guidewire That Improves Angioplasty
Procedures HAIFA, Israel, October 26 /PRNewswire-FirstCall/ --
Cardio Vascular Medical Device Corp. (OTC:CVSL), a leading
developer of advanced cardiovascular surgery technology, today
released a brief shareholders update. Cardio Vascular Medical
Device holds a US patent for an innovative next-generation
"steerable guidewire" applicable for all angioplasty (PCTA)
procedures. The guidewire has a unique opportunity to become the
guidewire of choice for surgeons throughout the world. The
technology hinges on a bendable tip that improves guidewire
performance, enables faster procedure completion, and provides cost
benefits for patients as well as healthcare providers. "Cardio
Vascular Medical Device has developed a technology that provides
several advantages over the current guidewires being employed in
angioplasty procedures," stated Eli Gonen, CEO of Cardio Vascular
Medical Device Corp. "And with well over 7 million angioplasties
performed each year, the global annual potential addressable market
in excess of $500 million." Cardio Vascular Medical Device is
working diligently to complete the development of the guidewire, in
preparation for full commercial distribution. Cardio Vascular
Medical Device Corp. plans to keep public shareholders informed of
all upcoming company developments. Forward-Looking Statements This
letter contains forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended and Section
21E of the Securities Exchange Act of 1934, as amended. All
forward-looking statements are inherently uncertain, based on
current expectations and assumptions concerning future events or
future performance of Cardio Vascular Medical Device Corp. and its
technologies. In evaluating such statements, prospective investors
should review carefully various risks and uncertainties identified
in this release, as actual results may differ materially from those
indicated in the forward-looking statements. Cardio Vascular
Medical Device Corp. public filings may be viewed at
http://www.sec.gov/. Contact: Alex Traiman, Media Relations,
+1-646-863-9729; Asher Zwebner, +972-54-464-6363, DATASOURCE:
Cardio Vascular Medical Device Corp. CONTACT: Contact: Alex
Traiman, Media Relations, +1-646-863-9729; Asher Zwebner,
+972-54-464-6363,
Copyright